Access Industries Holdings LLC 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-03-04 5:02 pm Sale | 2022-02-25 | 13D | Syndax Pharmaceuticals, Inc. SNDX | Access Industries Holdings LLC | 2,603,709 4.700% | -78,678 (-2.93%) | Filing |
| 2021-05-03 3:15 pm Purchase | 2021-04-21 | 13D | Syndax Pharmaceuticals, Inc. SNDX | Access Industries Holdings LLC | 2,682,387 5.560% | 544,187 (+25.45%) | Filing |
| 2021-02-03 8:14 pm Sale | 2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Access Industries Holdings LLC | 2,138,200 4.600% | -890,542 (-29.40%) | Filing |
| 2020-02-14 1:43 pm Purchase | 2019-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Access Industries Holdings LLC | 3,028,742 9.900% | 1,370,794 (+82.68%) | Filing |